Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of the American Pharmacists Association : Japha|February 13, 2026
Economic evaluation of talazoparib and enzalutamide compared to enzalutamide monotherapy in HRRm metastatic castration-resistant prostate cancerCaiden Lukan, Kangho Suh
Clinical Drug Investigation|February 26, 2026
Cost Effectiveness of Osimertinib with Chemotherapy Compared to Osimertinib Monotherapy and First-Generation EGFR-TKIs in Advanced NSCLC in the USAMohammad Alnuman, Kangho Suh
Epilepsia Open|September 15, 2025
Characterizing the burden of healthcare utilization and expenditure for epilepsy and unclassified seizures in the U.S., 2016-2022Pooja M Rajadhyaksha, Kangho Suh
The American Journal of Managed Care|May 13, 2022
Assessing surveillance utilization and value in commercially insured patients with colorectal cancerKangho Suh, Veena Shankaran, Aasthaa Bansal
Journal of Managed Care & Specialty Pharmacy|October 25, 2022
Trends in endpoint use in pivotal trials and efficacy for US Food and Drug Administration-approved solid tumor therapies, 1995-2021Orges Alabaku, Taylor N Laffey, Kangho Suh, et al.
Research in Social & Administrative Pharmacy : RSAP|September 3, 2014
Health economics and outcomes research fellowship practices reviewedKangho Suh, Susan Gabriel, Michelle A Adams, et al.
Pharmacoeconomics|March 1, 2018
Cost Effectiveness of Alectinib vs. Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung CancerJosh J Carlson, Kangho Suh, Panos Orfanos, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 23, 2015
Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary diseaseTzy-Chyi Yu, Huanxue Zhou, Kangho Suh, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 1, 2021
A systematic review of cost-effectiveness analyses across the acute kidney injury landscapeKangho Suh, John A Kellum, Sandra L Kane-Gill
Substance Use & Addiction Journal|May 8, 2024
Association of Opioid and Concurrent Benzodiazepine, Skeletal Muscle Relaxant, and Gabapentinoid Usage on Healthcare Expenditure and Resource Utilization: A Serial Cross-Sectional Study, 2009 to 2019Aryana Sepassi, Meng Li, Kangho Suh, et al.
Pageof 5